Follow-Up Care and 6-month Continuation Rates for Long-Acting Reversible Contraceptives in Adolescents and Young Adults: A Retrospective Chart Review.
Describe follow-up care patterns and continuation rates during the first 6-months after initiating a long-acting reversible contraceptive device (LARC) among adolescent and young adult (AYA) women. Retrospective chart review among patients who had an intrauterine device (IUD) or subdermal implant placed between January 2015 and December 2016. Urban adolescent specialty care clinic. Women ages 13-23 years. Follow up encounters were defined as scheduled and unscheduled phone calls, outpatient clinic visits, or emergency department visits during the 6-months after device placement. Continuation was defined as not having the device removed or expelled during the 6-months following initiation. Frequencies were calculated, and logistic regression was used to determine predictors of follow-up encounters and continuation. Among the 177 patients, 180 LARC devices were placed. Most were 13-17 years (56%), non-Hispanic Black (64%), publicly insured (57%), and had an IUD placed (57%). The majority (86%) had >1 clinical encounter during the 6-months: 70% attended a scheduled encounter and 53% had an unscheduled encounter. Half (45%) attended the scheduled 2-week office visit; only 6% attended the 6-month office visit. The 6-month LARC continuation rate was 92% (n=166), with most discontinuations among IUD users (n=12; 7%). LARC continuation rates were high in our study population. Most AYA women have at least one follow-up encounter in the 6-months following LARC placement. Clinical practices should be prepared to address issues that arise during follow-up encounters, whether in-person or by phone.